Hair loss

Pubic hair: beyond brazilians, more than manscaping

Retrieved on: 
Wednesday, April 10, 2024
Research, Health, Urinary tract infection, Gas, Vibration, Hair loss, Friction, Pressure, Facial expression, Science, Risk, Perspiration, Observation, Partner (business rank), Bacteria, Pheromone, Human, Woman, Body image, Sensation, Urine, Infection, Skin, Eyebrow, Scalp, Gland, Ammonia, Urea, Animal, Emotion

So, what about pubic hair?

Key Points: 
  • So, what about pubic hair?
  • Let’s talk about sex
    Much of the effort that goes into shaping or removing pubic hair also shapes and defines sexual identities.
  • While the properties of pheromones are not as well established in humans, there’s speculation that pubic hair plays a significant role.
  • Pubic hair grooming has been associated with an increased risk of genital infections but this has also been refuted.

AI-Integrated Robotic Hair Restoration Revolutionizes Quality Of Life At Dallas Men's Health

Retrieved on: 
Thursday, March 28, 2024
Health, DMH, Patient, Hair loss, ARTAS, Men's Health, Medical device

DALLAS, March 28, 2024 /PRNewswire/ -- Dallas Men's Health (DMH), a men's sexual health and aesthetics clinic, proudly introduces new additions to its line of services: ARTAS iXi, an AI-Integrated Robotic Hair Restoration solution.

Key Points: 
  • DALLAS, March 28, 2024 /PRNewswire/ -- Dallas Men's Health (DMH), a men's sexual health and aesthetics clinic, proudly introduces new additions to its line of services: ARTAS iXi, an AI-Integrated Robotic Hair Restoration solution.
  • The addition of these capabilities unites the 25 years of medical expertise from Dr. Michael Wierschem with the precision of AI-driven, robotic hair restoration solutions.
  • "Adding ARTAS AI-integrated Automated Hair Restoration to our suite of men's wellness services furthers our commitment to comfortably improve men's health and well-being.
  • The novel AI-driven robotic hair restoration service uses minimally-invasive follicle-unit extraction and implantation technology that does not leave a linear scar, promotes comfort, and requires less recovery time than other treatments.

Successful Dr.FORHAIR's Hair Loss Shampoo Launch Leads to Renewed 1-Year U.S. Costco Contract

Retrieved on: 
Wednesday, March 27, 2024
Sulfate, Gland, Paraben, Hair loss, Scalp, LOS, Silicon, Cosmetics

LOS ANGELES, March 27, 2024 /PRNewswire/ -- Dr.FORHAIR, a global scalp care brand sold 18,000 units of Folligen Original Shampoo at 50 U.S. locations within just 3 weeks of its first offline launch of the product. After successfully being sold online to the U.S. market, this clinically-proven hair loss prevention shampoo was launched in stores on October, 2023 across 50 American Costco branches. This award-winning shampoo was sold in Florida, New York, Hawaii, New Jersey, with a heavy focus on California. The explosive success for the brand's first U.S. in-store launch acts as a swift segue into a renewed 1-year contract with Costco beginning on June, 2024 in 250 Costco branches.

Key Points: 
  • After successfully being sold online to the U.S. market, this clinically-proven hair loss prevention shampoo was launched in stores on October, 2023 across 50 American Costco branches.
  • This award-winning shampoo was sold in Florida, New York, Hawaii, New Jersey, with a heavy focus on California.
  • The explosive success for the brand's first U.S. in-store launch acts as a swift segue into a renewed 1-year contract with Costco beginning on June, 2024 in 250 Costco branches.
  • After a successful launch, Dr.FORHAIR looks to gain more attention for its award-winning hair loss prevention shampoo.

Research case series presents food as medicine as a potential treatment for lupus and other autoimmune diseases

Retrieved on: 
Tuesday, March 19, 2024
Arthralgia, Series, Brain, Xerostomia, Face, Malar rash, Kidney, Lupus, Photosensitivity, Pleurisy, Inflammation, Patient, Raw foodism, Tissue, Research, History, Grit, Hair loss, Food, Seed, MD, Quality of life, Woman, Arthritis, Chronic pain, Skin, Water, Sunlight, Scalp, Immune system, Grain boundary strengthening, Frontiers, RRP, Fatigue, Swelling, Flax, Autoimmune disease, Nut, Medicine, Dietary supplement

ST. LOUIS, March 19, 2024 /PRNewswire-PRWeb/ -- A new research case series published in Frontiers in Nutrition presents food as medicine as a potential treatment for autoimmune diseases, describing three patients with chronic autoimmune disease who showed remarkable improvement after following a predominantly raw dietary pattern high in cruciferous vegetables and omega 3 fatty acids.

Key Points: 
  • ST. LOUIS, March 19, 2024 /PRNewswire-PRWeb/ -- A new research case series published in Frontiers in Nutrition presents food as medicine as a potential treatment for autoimmune diseases, describing three patients with chronic autoimmune disease who showed remarkable improvement after following a predominantly raw dietary pattern high in cruciferous vegetables and omega 3 fatty acids.
  • All three women reported that nearly all their symptoms of both diseases resolved after just four weeks of making the dietary changes.
  • "My hope is that these cases generate greater recognition, making patients and clinicians aware of food as medicine as a treatment option for systemic lupus erythematosus and Sjögren's syndrome.
  • This case series also reflects the immediate need for more research into dietary changes as a potential treatment strategy for autoimmune disease."

Celluma Light Therapy Introduces the RESTORE Hair Therapy System

Retrieved on: 
Thursday, March 14, 2024
DHT, Vitamin, Adenosine triphosphate, Serum, Inflammation, Zinc, Hair loss, Glycine, Scalp, ATP, FDA, Microcirculation, Peptide, Cosmetics

TUSTIN, Calif., March 14, 2024 /PRNewswire/ -- BioPhotas, Inc., the makers of Celluma Light Therapy and market leader in therapeutic LED light therapy devices, announced today the launch of the RESTORE Hair Serum, an optimized scalp and hair formulation that complements the award-winning Celluma RESTORE LED device to provide a complete hair-restoration solution.

Key Points: 
  • TUSTIN, Calif., March 14, 2024 /PRNewswire/ -- BioPhotas, Inc., the makers of Celluma Light Therapy and market leader in therapeutic LED light therapy devices, announced today the launch of the RESTORE Hair Serum, an optimized scalp and hair formulation that complements the award-winning Celluma RESTORE LED device to provide a complete hair-restoration solution.
  • "It's an amazingly elegant formulation that is clear and easily absorbed into the scalp so that it can be used daily to maximize the Celluma Light Therapy results."
  • For the growing number of professionals and individuals achieving significant and visible results with the FDA-cleared Celluma RESTORE Light Therapy device for hair restoration, this serum is an ideal complement for use between each light therapy treatment.
  • According to Mr. Cluff, "the Celluma RESTORE light therapy device has been available since receiving FDA-clearance for hair restoration in 2021.

Give Your Wash Day Experience a Brand-New Feel! Haircare Brand African Pride Introduces a Sensory Regimen with Its Newest Collection, Feel It Formula!

Retrieved on: 
Tuesday, March 12, 2024
Mineral oil, Sage oil, Target, Sulfate, Petroleum, Hair loss, Formula, Walmart, Peppermint, Rosemary, Scalp, SRP, Collection, Cosmetics

ATLANTA, March 12, 2024 /PRNewswire/ -- African Pride, the trusted and legacy haircare brand, proudly unveils its latest innovation – the 'Feel It Formula' haircare line. This 4-step collection is meticulously crafted to redefine the 'Wash Day Experience,' offering a sensory regimen that caters to all hair types, chemical, relaxed, or transitioning; restoring dry, damaged hair, and treating irritated scalps #feelthedifference.

Key Points: 
  • This 4-step collection is meticulously crafted to redefine the 'Wash Day Experience,' offering a sensory regimen that caters to all hair types, chemical, relaxed, or transitioning; restoring dry, damaged hair, and treating irritated scalps #feelthedifference.
  • The NEW African Pride 'Feel It Formula' line ignites your senses through stimulating fragrances, invigorating sensations, and nourishing formulas.
  • African Pride Feel It Formula Peppermint, Rosemary & Sage Strengthening Shampoo (SRP $6.99) - Deeply cleanses hair and scalp, removing product build-up without stripping moisture.
  • African Pride Feel It Formula Peppermint, Rosemary & Sage Strengthening Mask (SRP $6.99) - Strengthens and hydrates hair strands from root to tip.

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars

Retrieved on: 
Tuesday, February 27, 2024
NSCLC, Therapy, Reflection nebula, Ophthalmology, Marketing, Investigational New Drug, Immune system, Myelodysplastic syndrome, Immunotherapy, Collateral damage, Shogun, FDA, Dietary supplement, US FDA, Polysaccharide, Nausea, Grifola frondosa, Hair loss, CDMO, Safety, MDS, Fatigue, CNS, TNBC, Edible, Ergosterol, Patient, Quality of life, Drug, Immunity, IND, Cancer

The Investigational New Drug (IND) application proposed the clinical investigation of BLEX 404 as the primary active ingredient.

Key Points: 
  • The Investigational New Drug (IND) application proposed the clinical investigation of BLEX 404 as the primary active ingredient.
  • The global cancer therapeutics market is expected to be worth around US$ 393.61 billion by 2032 from US$ 164 billion in 2022, growing at a CAGR of 9.20% from 2023 to 2032.
  • [4] Straits Research reports that the global botanical drug market size was valued at $163 million in 2021 and is expected to be valued at $3.2 billion.
  • The market is expected to grow at a CAGR of 39% during the forecast period (2022–2030).

Stemson Therapeutics and Bosley Parent Company, Aderans, Sign Exclusive Hair Regeneration Licensing Deal

Retrieved on: 
Saturday, March 9, 2024
Health, Consumer, Genetics, Other Health, General Health, Men, Anxiety, Woman, Hair loss, Quality of life, Tissue engineering, Cell, Medicine, IPSC, Therapy, Patient, Research, Depression, Pharmaceutical industry

Stemson Therapeutics and Aderans Company , the parent company of Bosley ® and HAIRCLUB ®, today announced an agreement securing Stemson the exclusive global rights to research, develop and commercialize hair regeneration therapeutic products based on Aderans’ proprietary hair regeneration cell therapy technology.

Key Points: 
  • Stemson Therapeutics and Aderans Company , the parent company of Bosley ® and HAIRCLUB ®, today announced an agreement securing Stemson the exclusive global rights to research, develop and commercialize hair regeneration therapeutic products based on Aderans’ proprietary hair regeneration cell therapy technology.
  • Stemson will resume Aderans’ Phase 2 clinical stage cell therapy hair regeneration program, integrate the technology into its existing hair loss cell therapy development pipeline, and provide multiple products for patients experiencing hair loss.
  • Aderans’ proprietary hair regeneration platform is a cell therapy system that utilizes patient-derived hair and skin cells to durably rejuvenate shrinking hair follicles in patients with Androgenetic Alopecia by repopulating functional hair follicle cells into early-to-mid stage hair loss areas.
  • “Aderans’ early pioneering work in cell therapy for hair loss demonstrated to the field the potential for durable long lasting hair regeneration results by restoring functional hair cells and tissue.

“One of the Biggest Innovations in Hair Loss We’ve Seen in Twenty-Five Years” -- BosleyMD® Teams With Start-up Yuva Biosciences in National Launch of Breakthrough Technology

Retrieved on: 
Tuesday, February 20, 2024
Technology, Professional Services, Health, Marketing, Biometrics, Communications, Other Technology, Cosmetics, Retail, Data Analytics, Artificial Intelligence, Foam, Hospital, Procter, Senior, Woman, Research, Entrepreneurship, Multimedia, Artificial intelligence, Hair loss, Mitochondrion, News, Ageing, Human, MIT, Y100, Harvard University, Skin, Oil, Fertility, Crest, Skin care, University, Translation, Organization, P&G, Science, Longevity, Crest Whitestrips, Procter & Gamble, McKinsey & Company, Dietary supplement

BosleyMD® is rolling out its new Revive Plus Densifying Foam with YuvaBio® Y100™ technology for men and women to major national mass retailers, beauty chains, pharmacy chains, and e-commerce sites.

Key Points: 
  • BosleyMD® is rolling out its new Revive Plus Densifying Foam with YuvaBio® Y100™ technology for men and women to major national mass retailers, beauty chains, pharmacy chains, and e-commerce sites.
  • Critical pioneering science in mitochondrial science has been driven by Dr. Keshav K. Singh, Chief Scientific Officer and Co-Founder of Yuva Biosciences.
  • Yuva Biosciences experts used AI to identify molecules that could restore mitochondrial function, of which Y100 is the first to market out of the pipeline.
  • "Yuva Biosciences' technology solves this problem with once-in-a-generation innovation by fighting a key root cause of aging, mitochondrial dysfunction.

Pelage Presents Late-Breaking Data at AAD 2024 Meeting Demonstrating PP405 Activates Human Hair Follicle Stem Cells Ex Vivo and in Phase 1 Clinical Study

Retrieved on: 
Saturday, March 9, 2024
MPC, Woman, LDH, CMO, LOS, Hair loss, Blood, Pattern hair loss, Biopsy, Fur, Skin, Data, Annual general meeting, B cell, AAD, Patient, Clinical trial, Inhibitor, American Academy, Pharmaceutical industry

LOS ANGELES, March 9, 2024 /PRNewswire/ -- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company pioneering a new generation of treatments for hair loss, today presented positive translational and Phase 1 clinical data demonstrating the company's novel small molecule therapy PP405 reactivates dormant hair follicle stem cells to trigger hair growth. Data were presented in a late-breaking oral session of the American Academy of Dermatology (AAD) 2024 Annual Meeting in San Diego, titled Inhibition of pyruvate oxidation activates human hair follicle stem cells ex vivo.

Key Points: 
  • Data were presented in a late-breaking oral session of the American Academy of Dermatology (AAD) 2024 Annual Meeting in San Diego, titled Inhibition of pyruvate oxidation activates human hair follicle stem cells ex vivo.
  • "The translational data derived from our ex vivo studies on human facelift skin have been further validated in a Phase 1 first-in-human clinical trial demonstrating PP405 effectively reactivates dormant hair follicle stem cells," said Daniel Gil, Ph.D., CEO of Pelage Pharmaceuticals.
  • The LDH activity corresponded with a significant increase in Ki67 signal in the hair bulge, indicating a proliferative response of the hair follicle stem cells.
  • PP405 may also have applications for other forms of alopecia, including telogen effluvium (stress-induced hair loss) and chemotherapy-induced hair loss.